Published date: Dec 05 2018

Journal Title: KnE Life Sciences

Issue title: The 2nd International Conference on Hospital Administration (The 2nd ICHA)

Pages: 340–347

DOI: 10.18502/kls.v4i9.3584

Suherman .

A Nurwahyuniatikn.akk@gmail.com

Patient safety is now recognized as a priority by health systems around the world, drug-related problem is one of the component for patient safety assessment. The objective of this study is to systematically review the occurrence and preventability of Adverse Drug Events in hospitalized patients. This study uses systematic review based on the Prisma Protocol. A search was conducted on electronic databases such as ProQuest, SpringerLink, and Scopus using relevant keywords. The relevant studies were further selected using inclusion and exclusion criteria. Three studies were included in this review, two of which were research study by group and one was a dissertation study. All studies were conducted in hospitals. From the three journals, it can be seen that the incidence of ADE occurs in nearly all hospitals studied and that drug-related problems are still a significant burden for healthcare facilities. Adverse Drug Events are relevant problems in hospitalized patients. The occurrence of ADE was confirmed in all studies and ADE less can be prevented by the use of CPOE.

Keywords: adverse drugs events, medication-related problem, adverse drug reaction reporting system, hospitalized patients

[1] Komite Keselamatan Pasien Rumah Sakit. (2008). Pasien Rumah Sakit. Pedoman pelaporan insiden keselamatan pasien (IKP).


[2] C. B. (2008). A study of medication errors and adverse drug events in hospitalized patients.


[3] Al Hamid, A., Ghaleb, M., and Aljadhey, H. A. (2014). A systematic review of hospitalization resulting from medicine-related problems in adult patients. British Journal of Clinical Pharmacology, vol. 78, no. 2, pp. 202–217.


[4] Kongkaew, C., Noyce, P. R., and Ashcroft, D. M. (2008). Hospital admissions associated with adverse drug reactions: A systematic review of prospective observational studies. Annals of Pharmacotherapy, vol. 42, no. 7, pp. 1017–1025.


[5] Nebeker, J. and Barach, P. S. (2004). Clarifying adverse drug events: A clinician’s guide to terminology, documentation, and reporting. Annals of Internal Medicine, vol. 140, no. 10, pp. 795–801.


[6] World Health Organization. (2002). The Importance of Pharmacovigilance – Safety Monitoring of medicinal products.


[7] Bates, D., Boyle, D., Vander, V. M., et al. (1995). Relationship between medication errors and adverse drug events. Journal of General Internal Medicine, vol. 10, pp. 199–205.


[8] Morimoto, T., Gandhi, T., Seger, A., et al. (2004). Adverse drug events and medication errors: detection and classification methods. Quality and Safety in Health Care, vol. 13, pp. 306–314.


[9] Cano, F. G. and Rozenfeld, S. (2009). Adverse drug events in hospitals: A systematic review. Cadernos de Saúde Pública, vol. 25, pp. 360–372.


[10] Kohn, L. and Corrigan, J. D. (1999). To Err is Human: Building a Safer Health System. Washington DC: National Academy Press.


[11] van Doormaal, J. E., van den Bemt, P., and Mol, P. G. M. (2009). Medication errors: The impact of prescribing and transcribing errors on preventable harm in hospitalised patients. Quality and Safety in Health Care, vol. 18, pp. 22–27.


[12] Jolivot, P. A., Pichereau, C., Hindlet, P., et al. (2016). An observational study of adult admissions to a medical ICU due to adverse drug events. Annals of Intensive Care, vol. 6, no. 1, pp. 1–12.


[13] Dequito, A. B., Mol, P. G. M., van Doormaal, J. E., et al. (2011). Preventable and nonpreventable adverse drug events in hospitalized patients. Drug Safety, vol. 34, no. 11, pp. 1089–1100.